Group 1 - Fuda Alloy's controlling shareholder Wang Dawu plans to reduce his stake by up to 3% of the company's total shares, amounting to a maximum of 406.34 million shares, due to personal funding needs [1] - ST Songfa's subsidiary signed contracts for the construction of 17 vessels, with a total contract value between 1.6 billion to 1.8 billion USD [2] - Pairui Co. signed a technical cooperation agreement with a university to develop large-capacity power semiconductor devices and related power electronic modules, effective for three years [3] Group 2 - Shuangliang Energy indirectly participates in commercial aerospace projects, supplying heat exchangers for SpaceX's fuel production system, with orders totaling approximately 1.39 million CNY [4] - Hangya Technology plans to issue convertible bonds to raise up to 600 million CNY for various projects, including an intelligent manufacturing base in Malaysia [5] - Yuhua Development is publicly selling assets with a base price of 251 million CNY for residential properties [6] Group 3 - Penghui Energy plans to invest 2.1 billion CNY in a new battery production project in Zhengyang County, Henan Province, focusing on high-performance battery products [7] - Haige Communication's shareholder Yang Haizhou intends to reduce his stake by up to 0.1624% of the company's total shares [8] - Yaoshi Technology's controlling shareholder pledged 5.13% of shares to repay loans, with a pledge period from February 10, 2026, to February 2, 2027 [9][10] Group 4 - Hanyu Pharmaceutical received FDA approval for its drug Acetate Glatiramer Injection, used for treating relapsing multiple sclerosis [11] - Baiyao Tai's GoliMab Injection received EMA approval for various indications, including rheumatoid arthritis and ulcerative colitis [12] - Jiangxi Tungsten Equipment plans to issue A-shares to raise up to 1.882 billion CNY for acquisitions [13] Group 5 - Hesong New Materials expects to recognize asset impairment provisions between 23.6 million to 28.5 million CNY for 2025 [14] - ST Meichen's subsidiary is involved in two major lawsuits with a total amount of approximately 31.9 million CNY [15] - China Coal Energy reported a 7.3% year-on-year decline in coal sales for January 2026, with total sales of 20.05 million tons [16] Group 6 - Yida Co. plans to adjust its epoxy propylene derivative project, reducing the total investment from 845 million CNY to 642 million CNY [17] - Fosun Pharma's subsidiary received approval for a clinical trial of HLX15-SC for multiple myeloma treatment [18][19] - Yinfeng Communication's board members and executives have terminated their share reduction plan [20] Group 7 - Huazhong High-tech has waived its preferential purchase rights for a fund, extending the investment period from three to four years [21] - Warner Pharmaceuticals plans to participate in a national drug procurement program, with expected sales of 176 million CNY [22] - Changling Hydraulic announced a tender offer to acquire 12% of its shares at a price of 35.82 CNY per share [23] Group 8 - ST Chuan Zhi's stock may face delisting due to financial data falling below regulatory thresholds [24] - Tian Pharmaceutical and its subsidiaries are participating in a national drug procurement program, with expected sales of 323 million CNY [25] - China Metallurgical Group signed new contracts worth 73.65 billion CNY in January 2026 [26] Group 9 - Torus plans to invest 21.2 million CNY in a venture capital fund focused on artificial intelligence [27] - Shangwei Co. received a government subsidy of 1.764 million CNY, representing 10.79% of its net profit for 2024 [28] - Hanghua Co. reported a 21.97% decline in net profit for 2025, with total revenue of 1.249 billion CNY [29] Group 10 - Huaxia Bank reported a 1.72% decline in net profit for 2025, with total revenue of 91.914 billion CNY [30] - Guotou Fengle plans to transfer 51% of its stake in Hubei Fengle Ecological Fertilizer to optimize management [31] - Huaru Technology is co-investing in a fund with a total commitment of 20 million CNY [32] Group 11 - Jindike reported a loss of 173 million CNY for 2025, despite a 40.13% increase in revenue [33] - Zhenong Co. announced a 0.52% increase in shares held by a major shareholder [34] - Maike Audi plans to recognize asset impairment provisions of approximately 52.55 million CNY [35] Group 12 - Fuan Pharmaceutical's subsidiary is expected to be selected for a national drug procurement program, with projected sales of 680 million CNY [36] - Rundu Co. is participating in a national drug procurement program, with some products expected to be selected [37] - Changqing Co. has postponed its large-scale die-casting project to March 2027 due to customer requirements [38] Group 13 - Pan Asia Micro透 received a patent for a graphene-based automotive headlight defogging device [39] - Luan An Huan Neng reported a 17.1% increase in raw coal production for January 2026, totaling 5 million tons [40] - Guangji Pharmaceutical received a drug registration certificate for Mecobalamin Tablets [41] Group 14 - Ruifeng New Materials announced the resignation of its deputy general manager for personal reasons [42] - Zhiguang Electric's subsidiary signed a procurement contract for energy storage equipment worth 210.4 million CNY [43] - Youyan Powder Materials reported a 19.41% increase in net profit for 2025 [44] Group 15 - Jincheng reported a 22.2% increase in net profit for 2025, with total revenue of 253 million CNY [46]

（记者 王晓波） 每经头条（nbdtoutiao）——打造百万元级尊界的江淮，迎来葛卫东、方文艳联手投资：两人各掏10亿 元，公司股价应声大涨！复盘历史：牛散参与定增有赚也有亏 每经AI快讯，东湖高新2月12日晚间发布公告称，公司第十届第二十六次董事会会议于2026年2月11日 以通讯方式召开。会议审议了《关于修改基金合伙协议暨关联交易的议案》等文件。 ...

募集资金管理制度 武汉东湖高新集团股份有限公司 WUHANEASTLAKEHI-TECHGROUPCO.,LTD. 募集资金管理制度 2026年 月 日修订 2026年 月 日施行 本文件为武汉东湖高新集团股份有限公司版权所有，未经许可不得影印 1 募集资金管理制度 第一章 总则 第一条 为规范武汉东湖高新集团股份有限公司（以下简称"公司"）募集资 金的管理和运用，提高募集资金的使用效率，防范资金使用风险，确保资金使 用安全，切实保护投资者的合法权益，根据《中华人民共和国公司法》《中华人 民共和国证券法》《首次公开发行股票注册管理办法》《上市公司证券发行注册 管理办法》《上市公司信息披露管理办法》《上市公司募集资金监管规则》《上海 证券交易所股票上市规则（2025 年修订）》（以下简称"《上市规则》"）《上海证 券交易所上市公司自律监管指引第 1 号——规范运作》等相关法律、法规和规 范性文件的规定，结合公司实际情况，制定本制度。 第二条 本制度适用于公司通过发行股票或者其他具有股权性质的证券，向 投资者募集并用于特定用途的资金监管，但不包括公司为实施股权激励计划募 集的资金监管。本制度所称超募资金是指实际募 ...

证券代码：600133 证券简称：东湖高新 公告编号：临 2026-005 武汉东湖高新集团股份有限公司 关于放弃工控东高基金份额的优先购买权 及延长基金投资期并修改合伙协议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： | 投资标的名称 | 广州工控东高科技产业股权投资合伙企业（有限 | | | | --- | --- | --- | --- | | | 合伙） | | | | 投资金额（万元） | 公司认缴出资人民币 | | 24,500 万元； | | | 公司全资子公司武汉东湖高新股权投资管理有 | | | | | 限公司认缴出资人民币 | | 500 万元。 | | 投资进展阶段 | 完成 进展 募集失败 | 终止 | 交易要素变更 | | | 未能完成备案登记 提前终止 | | | | | 发生重大变更 | | | | | 其他： 截至本公告披露日，新的《合伙协议》 | | | | | 尚未正式签署。基金拟投资的项目可能受到（包 | | | | 特别风险提示（如有请勾选） ...

证券代码：600133 证券简称：东湖高新 公告编号：临 2026-003 武汉东湖高新集团股份有限公司 关于向合营公司武汉东新阳智科技发展有限公司 提供财务资助的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 为更好的促进合营公司武汉东新阳智科技发展有限公司（以下简称"东新 阳智"或"借款人"或"项目公司"）业务发展，武汉东湖高新集团股份有限公 司（以下简称"公司"或"东湖高新"）拟向东新阳智提供 900 万元借款，借款 期限为 12 个月，自首笔借款资金转入东新阳智指定银行账户之日起算，借款利 率按 4.5%/年计算，按季结息、按季付息，先息后本。东新阳智的其他股东也按 持股比例提供同等条件借款。 本次交易不构成《上海证券交易所股票上市规则》规定的关联交易，也不 构成《上市公司重大资产重组管理办法》规定的重大资产重组。本次交易已经公 司第十届董事会第二十六次会议审议通过，鉴于东新阳智最近一期财务报表资产 负债率未超过 70%，本次提供财务资助事项无需提交公司股东会审议。 本次财务资助事项不会影响公司正 ...

证券代码：600133 证券简称：东湖高新 公告编号：临 2026-004 武汉东湖高新集团股份有限公司 关于修改基金合伙协议暨关联交易的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 投资标的名称 嘉兴资卓股权投资基金合伙企业（有限合伙） 投资金额（万元） 4,500 投资进展阶段 完成 终止 交易要素变更 进展 特别风险提示（如有请勾选） 募集失败 未能完成备案登记 提前终止 发生重大变更 其他： 截至本公告披露日，新的《合伙协 议》尚未正式签署。敬请广大投资者理性投 资，注意风险。 一、合作投资基本概述情况 湖北省联合发展投资集团有限公司系公司间接控股股东，联投置业系联投集 团控股子公司，根据《上海证券交易所股票上市规则》的相关规定，联投置业为 公司关联方。本次拟与联投置业、光大浸辉签署《合伙协议（修改后）》将构成 经武汉东湖高新集团股份有限公司（以下简称"公司"或"东湖高新"）第 七届董事会第二十九次会议审议、第七届董事会第三十五次会议审议并通过了 《关于拟出资设立产业投资基金的议案》、《关于延长 ...

证券代码：600133 证券简称：东湖高新 公告编号：临 2026-002 武汉东湖高新集团股份有限公司 第十届董事会第二十六次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 武汉东湖高新集团股份有限公司（以下简称"公司"）第十届董事会第二十六 次会议通知及材料于 2026 年 2 月 6 日以电子邮件方式发出，于 2026 年 2 月 11 日以 通讯方式召开。本次会议应参加表决的董事 9 人，实际参加表决的董事 9 人。 本次会议的召开符合《公司法》和《公司章程》的有关规定。 二、董事会会议审议情况 1、审议通过了《关于向合营公司武汉东新阳智科技发展有限公司提供财务资 助的议案》； （1）同意公司与合营公司武汉东新阳智科技发展有限公司（以下简称"东新阳 智"）签署《借款合同》，向东新阳智提供借款总额不超过人民币 900 万元（含）， 借款期限为 12 个月，自首笔借款资金转入东新阳智指定银行账户之日起算； （2）借款利率与计息：借款利息按照年利率 4.5%计算，按季结息、按季付息， 先 ...

东湖高新公告称，公司于2026年2月11日召开董事会，审议通过修改嘉兴资卓股权投资基金合伙企业 （有限合伙）合伙协议的议案。基金经营期限由10年延长至15年，原协议其他条款不变。公司对该基金 出资4500万元，此次调整不涉及基金规模变更，不会对公司财务及经营产生重大影响。此外，公司与多 家私募基金合作投资，累计认缴出资额达11.41亿元，相关基金均已完成备案登记。 ...

东湖高新晚间公告，公司及全资子公司东湖投资放弃对工控东高基金优先购买权，基金投资期由3年延 长至4年，整体存续期限由7年调整为8年。公司认缴出资2.45亿元，占基金规模49%，东湖投资认缴500 万元，占1%，工控科产原认缴2.49亿元占49.8%，现转让给工控产业园。 ...

Core Insights - The digital cultural and creative industry is becoming a crucial direction for optimizing economic structure and cultivating new productive forces, with Wuhan's East Lake High-tech Zone (China's "Optics Valley") launching measures to promote the integration of technology and culture, focusing on AI and cultural collaboration, with subsidies up to 10 million yuan [1][2] Group 1: Policy Measures - The "Several Measures" emphasize "content is king," providing tiered rewards up to 1 million yuan based on viewership and downloads for original animations and games, and a 50% subsidy on game license application fees, with a cap of 200,000 yuan per company annually [2] - Support for high-quality IPs to extend into derivative products and cultural tourism, with rewards up to 100,000 yuan for companies with year-on-year growth in overseas revenue, alongside services for overseas exhibitions and copyright transactions [2] - The policy includes operational subsidies of up to 200,000 yuan annually for characteristic parks in gaming, e-sports, and animation, with a maximum support of 300,000 yuan for companies increasing R&D expenses [3] Group 2: Industry Development - The digital entertainment industry base is set to become a new landmark for the digital cultural and creative industry, with the first phase expected to create nearly 1,000 jobs and support upstream and downstream industries in e-sports talent management and content production [3][4] - The second phase of the digital entertainment industry base will include offices, e-sports training, venues, and hotels, aiming to attract quality enterprises and foster innovative business models [4] - The policy also focuses on talent cultivation, providing annual recommendations for quality enterprises under the 3551 talent policy, with selected talents receiving various support services [5]